Yoshiro Okubo Selected Research

Yoshiro Okubo Research Topics

Disease

30	Schizophrenia (Dementia Praecox) 05/2022 - 01/2002
5	Major Depressive Disorder (Major Depressive Disorders) 12/2019 - 06/2010
5	Psychotic Disorders (Schizoaffective Disorder) 01/2016 - 01/2002
4	Pain (Aches) 01/2022 - 06/2014
4	Alzheimer Disease (Alzheimer's Disease) 01/2017 - 01/2014
3	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 11/2021 - 04/2014
3	Anhedonia 08/2020 - 08/2014
3	Bipolar Disorder (Manic Depressive Psychosis) 01/2016 - 01/2014
3	Dementia (Dementias) 01/2016 - 10/2013
3	Cognitive Dysfunction 08/2015 - 05/2015
3	Mental Disorders (Mental Disorder) 08/2014 - 08/2008
2	Parkinson Disease (Parkinson's Disease) 01/2022 - 01/2021
2	Multiple Sclerosis 01/2022 - 12/2021
2	Narcolepsy 11/2021 - 05/2014
2	Substance-Related Disorders (Drug Abuse) 09/2018 - 06/2014
2	Tobacco Use Disorder (Nicotine Dependence) 01/2017 - 05/2008
2	Delirium 01/2016 - 08/2012
2	Atrophy 07/2015 - 05/2015
2	Feeding and Eating Disorders (Eating Disorder) 01/2015 - 06/2014
2	Mania (Manias) 01/2015 - 01/2014
2	Mood Disorders (Mood Disorder) 01/2014 - 05/2002
2	Hyperprolactinemia 04/2013 - 09/2010
2	Epilepsy (Aura) 01/2007 - 12/2002
2	Temporal Lobe Epilepsy 01/2007 - 02/2004
1	Stroke (Strokes) 01/2022
1	Spinal Cord Injuries (Spinal Cord Injury) 01/2022
1	Cerebellar Diseases (Cerebellar Syndrome) 01/2022
1	Treatment-Resistant Depressive Disorder 11/2021
1	Back Pain (Backache) 10/2020
1	Neck Pain (Cervicalgia) 10/2020
1	Obesity 12/2019
1	Chronic Pain 11/2019
1	Frailty 11/2019
1	Chronic Disease (Chronic Diseases) 01/2019
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2017
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2016
1	Shock 01/2016
1	Borderline Personality Disorder (Personality Disorders, Borderline) 06/2014
1	Bulimia (Binge Eating) 06/2014
1	Mobility Limitation (Difficulty Walking) 09/2012
1	Catatonia 08/2012
1	Gambling (Pathological Gambling) 12/2010

Drug/Important Bio-Agent (IBA)

12	Pharmaceutical PreparationsIBA 01/2015 - 01/2002
11	Antipsychotic Agents (Antipsychotics)IBA 05/2022 - 03/2004
11	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 05/2022 - 01/2002
10	Dopamine (Intropin)FDA LinkGeneric 08/2020 - 06/2004
8	Biomarkers (Surrogate Marker)IBA 01/2017 - 04/2009
5	blonanserinIBA 05/2022 - 04/2013
5	Risperidone (Risperdal Consta)FDA LinkGeneric 01/2016 - 03/2004
5	FLB 457IBA 04/2013 - 01/2002
3	Modafinil (Provigil)FDA Link 11/2021 - 05/2014
3	RacloprideIBA 11/2017 - 12/2006
3	Amyloid beta-PeptidesIBA 01/2017 - 05/2015
3	florbetapirIBA 08/2015 - 05/2015
3	Amyloid (Amyloid Fibrils)IBA 07/2015 - 01/2014
3	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2015 - 01/2014
3	Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA 04/2014 - 08/2008
3	Olanzapine (Zyprexa)FDA Link 08/2012 - 06/2010
2	Tramadol (K315)FDA LinkGeneric 09/2018 - 06/2014
2	Nicotine FDA Link 01/2017 - 05/2008
2	Fluvoxamine (Luvox)FDA LinkGeneric 01/2016 - 10/2013
2	Yi-Gan SanIBA 01/2016 - 10/2013
2	MethoxyhydroxyphenylglycolIBA 01/2015 - 01/2014
2	Serotonin (5 Hydroxytryptamine)IBA 06/2014 - 06/2013
2	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 05/2014 - 10/2009
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2014 - 04/2008
2	GABA-A Receptors (GABA(A) Receptor)IBA 08/2010 - 02/2008
2	Antidepressive Agents (Antidepressants)IBA 08/2008 - 05/2002
2	5-HT1A Serotonin ReceptorIBA 01/2007 - 03/2004
2	Protons (Proton)IBA 06/2006 - 02/2004
2	Biological ProductsIBA 12/2002 - 01/2002
1	cyclo(Arg-Pro) (CI 4)IBA 01/2022
1	5-HT1B Serotonin ReceptorIBA 11/2021
1	Ketamine FDA LinkGeneric 11/2021
1	Dopamine D3 ReceptorsIBA 05/2021
1	naxagolideIBA 05/2021
1	TabletsIBA 01/2021
1	2- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA 01/2021
1	Bupropion (Wellbutrin)FDA LinkGeneric 12/2019
1	Therapeutic UsesIBA 01/2019
1	Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric 01/2019
1	N-n-propylnorapomorphineIBA 11/2017
1	Opioid Receptors (Opioid Receptor)IBA 06/2014
1	Wakefulness-Promoting AgentsIBA 05/2014
1	Nortriptyline (Aventyl)FDA LinkGeneric 04/2014
1	Milnacipran (Ixel)FDA Link 06/2013
1	ProlactinIBA 04/2013
1	Hormones (Hormone)IBA 01/2013
1	A-factor (Streptomyces)IBA 04/2012
1	Haloperidol (Haldol)FDA LinkGeneric 09/2010
1	Sulpiride (neogama)IBA 09/2010
1	Indicators and Reagents (Reagents)IBA 09/2010

Therapy/Procedure

2	Activities of Daily Living (ADL) 07/2015 - 09/2012
1	Transdermal Patch 05/2022
1	Neurological Rehabilitation 12/2021
1	Polypharmacy 10/2020
1	Pain Management 11/2019
1	Wearable Electronic Devices 01/2019
1	Therapeutics 01/2016
1	Drug Therapy (Chemotherapy) 01/2016